-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ShR7xHghRgtoVRQkD98kya6pv2VJBBUOSKqQw9EuEtTgVueAoaTI3l5V9Z2+0CA1 fwW8LT302y9QzlOhtdtRFQ== 0000950162-01-500538.txt : 20010804 0000950162-01-500538.hdr.sgml : 20010804 ACCESSION NUMBER: 0000950162-01-500538 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010802 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SIGMA TAU FINANZIARIA CENTRAL INDEX KEY: 0001092601 STANDARD INDUSTRIAL CLASSIFICATION: TEXTILE MILL PRODUCTS [2200] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: VIA SUDAFRICA 20 STREET 2: 00144 CITY: ROME ITALY MAIL ADDRESS: STREET 1: VIA SUDAFRICA 20 STREET 2: 00144 CITY: ROME ITALY SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: QUESTCOR PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000891288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330476164 STATE OF INCORPORATION: CA FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-43062 FILM NUMBER: 1696405 BUSINESS ADDRESS: STREET 1: 26118 RESEARCH ROAD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5107325551 MAIL ADDRESS: STREET 1: 26118 RESEARCH ROAD CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: CYPROS PHARMACEUTICAL CORP DATE OF NAME CHANGE: 19930328 SC 13G 1 questcor13g.txt AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Amendment No.1 Under the Securities Exchange Act of 1934 Questcor Pharmaceuticals, Inc. (formerly Cypros Pharmaceuticals Corporation) - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, No Par Value - -------------------------------------------------------------------------------- (Title of Class of Securities) 232808105 - -------------------------------------------------------------------------------- (CUSIP Number) July 26, 2001 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: / / Rule 13d-1(b) -- /X/ Rule 13d-1(c) -- / / Rule 13d-1(d) -- *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP 232808105 SCHEDULE 13G -2- - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. - -------------------------------------------------------------------------------- I.R.S. Identification Nos. of above persons (entities only). Sigma-Tau Finanziaria SpA - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) / / -- (b) / / -- - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Italy - -------------------------------------------------------------------------------- 5. Sole Voting Power 2,893,563 ----------------------------------------------------- Number of 6. Shared Voting Power Shares Beneficially 0 Owned by Each ----------------------------------------------------- Reporting 7. Sole Dispositive Power Person With: 2,893,563 ----------------------------------------------------- 8. Shared Dispositive Power 0 - - ------------------------------------------------------------------------------ 9. Aggregate Amount Beneficially Owned by Each Reporting Person 2,893,563 - -------------------------------------------------------------------------------- 10. Check box if the Aggregate Amount in Row (9) Excludes / / -- Certain Shares (See Instructions) - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9) 9.92% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) CO - -------------------------------------------------------------------------------- CUSIP 232808105 SCHEDULE 13G -3- - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Sigma-Tau Finance Holding S.A. - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) / / -- (b) / / -- - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Luxembourg - -------------------------------------------------------------------------------- 5. Sole Voting Power 2,893,563 ----------------------------------------------------- Number of 6. Shared Voting Power Shares Beneficially 0 Owned by Each ----------------------------------------------------- Reporting 7. Sole Dispositive Power Person With: 2,893,563 ----------------------------------------------------- 8. Shared Dispositive Power 0 - - ------------------------------------------------------------------------------ 9. Aggregate Amount Beneficially Owned by Each Reporting Person 2,893,563 - -------------------------------------------------------------------------------- 10. Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) / / -- - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9) 9.92% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) CO CUSIP 232808105 SCHEDULE 13G -4- - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Claudio Cavazza - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) / / -- (b) / / -- - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Italy - -------------------------------------------------------------------------------- 5. Sole Voting Power 4,330,344 ------------------------------------------------------ Number of 6. Shared Voting Power Shares Beneficially 0 Owned by Each ------------------------------------------------------ Reporting 7. Sole Dispositive Power Person With: 4,330,344 ------------------------------------------------------ 8. Shared Dispositive Power 0 - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 4,330,344 - -------------------------------------------------------------------------------- 10. Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9) 14.85% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) IN CUSIP 232808105 SCHEDULE 13G -5- - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Paolo Cavazza - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) / / -- (b) / / -- - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Italy - -------------------------------------------------------------------------------- 5. Sole Voting Power 4,330,345 ----------------------------------------------------- Number of 6. Shared Voting Power Shares Beneficially 0 Owned by Each ----------------------------------------------------- Reporting 7. Sole Dispositive Power Person With: 4,330,345 ----------------------------------------------------- 8. Shared Dispositive Power 0 - - ------------------------------------------------------------------------------ 9. Aggregate Amount Beneficially Owned by Each Reporting Person 4,330,345 - -------------------------------------------------------------------------------- 10. Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) / / -- - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9) 14.85% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) IN CUSIP 232808105 SCHEDULE 13G -6- Item 1(a). Name of Issuer: Questcor Pharmaceuticals, Inc. (formerly Cypros Pharmaceuticals Corporation) ("Questcor"). Item 1(b). Address of Issuer's Principal Executive Offices: 3260 Whipple Road Union City, CA 94587 Item 2(a). Name of Person Filing: This statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons") (1) Sigma-Tau Finanziaria SpA ("Sigma-Tau") (2) Sigma-Tau Finance Holding S.A., a wholly owned subsidiary of Sigma-Tau ("Holding"). (3) Claudio Cavazza ("Mr. C. Cavazza") (4) Paolo Cavazza ("Mr. P. Cavazza") Item 2(b). Address of Principal Business Office: (1) Sigma-Tau Via Sudafrica, 20 00144 Rome Italy (2) Holding 19-21 Boulevard du Prince Henri L-1724 Luxembourg (3) Mr. C. Cavazza Via Sudafrica, 20 00144 Rome Italy (4) Mr. P. Cavazza Via Sudafrica, 20 00144 Rome Italy Item 2(c). Citizenship: (1) Sigma-Tau is an Italian corporation. (2) Holding is a Luxembourg corporation. (3) Mr. C. Cavazza is an Italian Citizen. CUSIP 232808105 SCHEDULE 13G -7- (4) Mr. P. Cavazza is an Italian Citizen. Item 2(d). Title of Class of Securities: Common Stock, no par value (the "Shares") Item 2(e). CUSIP Number: 232808105 Item 3. If this statement is filed pursuant to ss.ss.240.13d-1(b) or 240.13d-2(b) or (c), check whether the person is a: This Item 3 is not applicable CUSIP 232808105 SCHEDULE 13G -8-
Item 4. Ownership: (1) Sigma-Tau (a) Amount beneficially owned: 2,893,563(a) (b) Percent of class: 9.92% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 2,893,563 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 2,893,563 (iv) shared power to dispose or to direct the disposition of: 0 (2) Holding (a) Amount beneficially owned: 2,893,563(a) (b) Percent of class: 9.92% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 2,893,563 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 2,893,563 (iv) shared power to dispose or to direct the disposition of: 0 (3) Mr. C. Cavazza -------------- (a) Amount beneficially owned: 4,330,344(b) (b) Percent of class: 14.85% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 4,330,344 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 4,330,344 (iv) shared power to dispose or to direct the disposition of: 0 (4) Mr. P. Cavazza -------------- (a) Amount beneficially owned: 4,330,345(c) (b) Percent of class: 14.85% (c) Number of shares as to which such person has: CUSIP 232808105 SCHEDULE 13G -9- (i) sole power to vote or to direct the vote: 4,330,345 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 4,330,345 (iv) shared power to dispose or to direct the disposition of: 0
--------- (a): All of the Shares are held by Holding and are restricted shares subject to certain limitations on resale. (b): 2,893,563 of the Shares beneficially owned are held by Holding and are restricted shares subject to certain limitations on resale. 1,436,781 of the Shares beneficially owned are issuable upon exercise of a Warrant. (c): 2,893,563 of the Shares beneficially owned are held by Holding and are restricted shares subject to certain limitations on resale. 1,436,782 of the Shares beneficially owned are issuable upon exercise of a Warrant. Item 5. Ownership of Five Percent or Less of a Class: Not Applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person: Not Applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company: Not Applicable Item 8. Identification and Classification of Members of the Group: Not Applicable Item 9. Notice of Dissolution of Group: Not Applicable Item 10. Certification: By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. CUSIP 232808105 SCHEDULE 13G -10- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: August 2, 2001 SIGMA TAU FINANZIARIA SPA By: /s/ Piero Belletti ------------------------------------------ Name: Piero Belletti Title: Director SIGMA TAU FINANCE HOLDING S.A. By: /s/ Maurizio Terenzi ------------------------------------------ Name: Maurizio Terenzi Title: Director CLAUDIO CAVAZZA By: /s/ Claudio Cavazza ------------------------------------------ Name: Claudio Cavazza PAOLO CAVEZZA By: /s/ Paolo Cavazza ------------------------------------------ Name: Paolo Cavazza CUSIP 232808105 SCHEDULE 13G -11- EXHIBIT INDEX Page No. A. Joint Filing Agreement dated August 2, 2001 by and among the Reporting Persons.......................................12 CUSIP 232808105 SCHEDULE 13G -12- EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Questcor Pharmaceuticals, Inc. dated as of August 2, 2001 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(f) under the Securities Exchange Act of 1934. Dated: August 2, 2001 SIGMA TAU FINANZIARIA SPA By: /s/ Piero Belletti ---------------------------------------- Name: Piero Belletti Title: Director SIGMA TAU FINANZIARIA SPA Dated: August 2, 2001 By: /s/ Maurizio Terenzi ---------------------------------------- Name: Maurizio Terenzi Title: Director Dated: August 2, 2001 CLAUDIO CAVAZZA By: /s/ Claudio Cavazza ---------------------------------------- Name: Claudio Cavazza Dated: August 2, 2001 PAOLO CAVAZZA By: /s/ Paolo Cavazza ---------------------------------------- Name: Paolo Cavazza -----END PRIVACY-ENHANCED MESSAGE-----